drugset / Trial / NCT01923376
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate whether the use of polyethylene glycol is superior and more safe in treating hepatic encephalopathy compared to lactulose and also to determine if treatment with polyethylene glycol will reduce the duration of hospital stay.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactulose | Other / unclassified | 10 g | — |
| Subject | Lactulose | Other / unclassified | 30 g | — |
| Comparator | polyethylene glycol | Other / unclassified | 1 unknown | — |